{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,5]],"date-time":"2026-04-05T09:40:07Z","timestamp":1775382007147,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.biopha.2017.06.001","type":"journal-article","created":{"date-parts":[[2017,6,12]],"date-time":"2017-06-12T16:35:55Z","timestamp":1497285355000},"page":"1095-1102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"special_numbering":"C","title":["Effect of Intravenous immunoglobulin on Th1 and Th2 lymphocytes and improvement of pregnancy outcome in recurrent pregnancy loss (RPL)"],"prefix":"10.1016","volume":"92","author":[{"given":"Majid","family":"Ahmadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samaneh","family":"Abdolmohammadi-vahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahnaz","family":"Ghaebi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leili","family":"Aghebati-Maleki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir","family":"Afkham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahla","family":"Danaii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sedigheh","family":"Abdollahi-Fard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lida","family":"Heidari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farhad","family":"Jadidi-Niaragh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahid","family":"Younesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2017.06.001_bib0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ogc.2014.10.002","article-title":"Recurrent pregnancy loss: evaluation and treatment","volume":"42","author":"Shahine","year":"2015","journal-title":"Obstet. Gynecol. Clin. North Am."},{"issue":"3","key":"10.1016\/j.biopha.2017.06.001_bib0010","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1529-1049(02)00046-6","article-title":"Intravenous immunoglobulin (IVIG) therapy for immunologic abortion","volume":"2","author":"Stricker","year":"2002","journal-title":"Clin. Appl. Immunol. Rev."},{"issue":"1","key":"10.1016\/j.biopha.2017.06.001_bib0015","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/aji.12442","article-title":"Intravenous immunoglobulin G improves pregnancy outcome in women with recurrent pregnancy losses with cellular immune abnormalities","volume":"75","author":"Lee","year":"2016","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.biopha.2017.06.001_bib0020","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1600-0897.2010.00852.x","article-title":"Th1\/Th2\/Th17 and regulatory T-Cell paradigm in pregnancy","volume":"3","author":"Saito","year":"2010","journal-title":"Am. Reprod. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2017.06.001_bib0025","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0167-5699(97)01127-4","article-title":"Th 1-type immunity is incompatible with successful pregnancy","volume":"18","author":"Raghupathy","year":"1997","journal-title":"Immunol. Today"},{"issue":"4","key":"10.1016\/j.biopha.2017.06.001_bib0030","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1515\/CCLM.2004.065","article-title":"Intravenous immunoglobulin (IVIG): modes of action in the clinical management of recurrent pregnancy loss (RPL) and selected autoimmune disorders","volume":"42","author":"Omwandho","year":"2004","journal-title":"Clin. Chem. Lab. Med."},{"issue":"10","key":"10.1016\/j.biopha.2017.06.001_bib0035","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1056\/NEJMra993360","article-title":"Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin","volume":"345","author":"Kazatchkine","year":"2001","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.biopha.2017.06.001_bib0040","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nri3401","article-title":"Intravenous immunoglobulin therapy: how does IgG modulate the immune system?","volume":"13","author":"Schwab","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2017.06.001_bib0045","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0165-0378(94)00918-W","article-title":"Intravenous immunoglobulin infusion therapy in women with recurrent spontaneous abortions of immune etiologies","volume":"28","author":"Kwak","year":"1995","journal-title":"J. Reprod. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2017.06.001_bib0050","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1365-3083.1993.tb02591.x","article-title":"Immune modulatory effects of immunoglobulins on cell-mediated immune responses in vitro","volume":"38","author":"Klaesson","year":"1993","journal-title":"Scand. J. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2017.06.001_bib0055","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaci.2010.10.030","article-title":"The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders","volume":"127","author":"Ballow","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2017.06.001_bib0060","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-0897.2012.01169.x","article-title":"Intravenous immunoglobulin for repeated IVF failure and unexplained infertility","volume":"68","author":"Virro","year":"2012","journal-title":"Am. J. Reprod. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2017.06.001_bib0065","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/BF00918683","article-title":"Suppression of immunoglobulin production of lymphocytes by intravenous immunoglobulin","volume":"11","author":"Kondo","year":"1991","journal-title":"J. Clin. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2017.06.001_bib0070","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/aji.12217","article-title":"Experience in IVIg therapy for selected women with recurrent reproductive failure and NK cell expansion","volume":"71","author":"Ramos-Medina","year":"2014","journal-title":"Am. J. Reprod. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2017.06.001_bib0075","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1385\/CRIAI:29:3:327","article-title":"Intravenous immunoglobulin and recurrent pregnancy loss","volume":"29","author":"Carp","year":"2005","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2017.06.001_bib0080","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1034\/j.1600-0897.2003.01169.x","article-title":"Effect of intravenous immunoglobulin treatment on the Th1\/Th2 balance in women with recurrent spontaneous abortions","volume":"49","author":"Graphou","year":"2003","journal-title":"Am. J. Reprod. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2017.06.001_bib0085","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1034\/j.1600-0897.2003.01184.x","article-title":"Intravenous immunoglobulin treatment in women with recurrent abortions: increased cytokine levels and reduced Th1\/Th2 lymphocyte ratio in peripheral blood","volume":"49","author":"Yamada","year":"2003","journal-title":"Am. J. Reprod. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2017.06.001_bib0090","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1600-0897.2012.01115.x","article-title":"The balance of the immune system between T cells and NK cells in miscarriage","volume":"67","author":"Nakashima","year":"2012","journal-title":"Am. J. Reprod. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2017.06.001_bib0095","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/aji.12259","article-title":"Characterization of uterine NK cells in women with infertility or recurrent pregnancy loss and associated endometriosis","volume":"72","author":"Giuliani","year":"2014","journal-title":"Am. J. Reprod. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2017.06.001_bib0100","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1600-0897.2011.01018.x","article-title":"Elevated preconception CD56+ 16+ and\/or Th1: Th2 levels predict benefit from IVIG therapy in subfertile women undergoing IVF","volume":"66","author":"Winger","year":"2011","journal-title":"Am. J. Reprod. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2017.06.001_bib0105","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.fertnstert.2012.06.048","article-title":"Evaluation and treatment of recurrent pregnancy loss: a committee opinion","volume":"98","author":"P.C.o.t.A.S.f.R. Medicine","year":"2012","journal-title":"Fertil. Steril."},{"issue":"5","key":"10.1016\/j.biopha.2017.06.001_bib0110","first-page":"398","article-title":"Determination of clinical cellular immune markers in women with recurrent pregnancy loss","volume":"70","author":"Lee","year":"2013","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.biopha.2017.06.001_bib0115","series-title":"Alloimmune Causes of Recurrent Pregnancy Loss, Seminars in Reproductive Medicine","first-page":"393","author":"Porter","year":"2000"},{"issue":"4","key":"10.1016\/j.biopha.2017.06.001_bib0120","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/humrep\/deg156","article-title":"Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF","volume":"18","author":"Kwak-Kim","year":"2003","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.biopha.2017.06.001_bib0125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1600-0897.1999.tb00081.x","article-title":"Natural killer (NK) cell subsets and NK cell cytotoxicity in women with histories of recurrent spontaneous abortions","volume":"41","author":"Gilman-Sachs","year":"1999","journal-title":"Am. J. Reprod. Immunol."},{"issue":"8607","key":"10.1016\/j.biopha.2017.06.001_bib0130","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0140-6736(88)92859-0","article-title":"Lupus anticoagulant and recurrent fetal loss: successful treatment with gammaglobulin","volume":"332","author":"Carreras","year":"1988","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.biopha.2017.06.001_bib0135","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/j.1600-0897.1996.tb00496.x","article-title":"Intravenous immunoglobulin inhibits natural killer cell activity in vivo in women with recurrent spontaneous abortion","volume":"35","author":"Ruiz","year":"1996","journal-title":"Am. J. Reprod. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2017.06.001_bib0140","doi-asserted-by":"crossref","first-page":"745","DOI":"10.4049\/jimmunol.132.2.745","article-title":"Modulation of mononuclear phagocyte function by intravenous gamma-globulin","volume":"132","author":"Kimberly","year":"1984","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2017.06.001_bib0145","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1600-065X.1989.tb00031.x","article-title":"Anti-idiotypes against autoantibodies in normal immunoglobulins: evidence for network regulation of human autoimmune responses","volume":"110","author":"Rossi","year":"1989","journal-title":"Immunol. Rev."},{"issue":"8","key":"10.1016\/j.biopha.2017.06.001_bib0150","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0161-5890(83)90076-7","article-title":"Interaction of C3 and C3b with immunoglobulin G","volume":"20","author":"Kulics","year":"1983","journal-title":"Mol. Immunol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217310545?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217310545?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T07:44:38Z","timestamp":1772264678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217310545"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":30,"alternative-id":["S0753332217310545"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.06.001","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Intravenous immunoglobulin on Th1 and Th2 lymphocytes and improvement of pregnancy outcome in recurrent pregnancy loss (RPL)","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}